December 23, 2024--Arrowhead Pharmaceuticals ... to receive up to 44,350 restricted stock units. The grants are outside the Company’s stockholder-approved equity incentive plans and PASADENA ...

State Street Corp raised its stake in Arrowhead Pharmaceuticals by 8.8% during the third quarter. State Street Corp now owns 6,354,331 shares of the biotechnology company’s stock worth $ ...

An insider trading activity happens when corporate insiders trade in stock in their own companies. Insider trading information is an indicator that can be used to gain valuable insights and as a ...

Arrowhead Pharmaceuticals said Friday that the Food and Drug Administration accepted the company's new drug application for its treatment of familial chylomicronemia syndrome, a severe and rare ...

Hamilton James C, Chief of Discovery/Trans Medicine at Arrowhead Pharmaceuticals ... The transaction comes as the stock has declined over 50% in the past year, with InvestingPro data showing ...

Short interest and days to cover can be used to indicate market sentiment and gauge the stock market in an investor’s analysis. Please note: If days to cover is between 0 and 1, it is rounded up ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug Administration (FDA) has accepted ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Arrowhead Pharmaceuticals (ARWR ... smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

CEO Christopher Richard Anzalone sold 11,520 shares of the stock in a transaction that occurred on Thursday, January 2nd. The ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...